RWD128 Profile of Patients with Multiple Sclerosis on Oral Disease-Modifying Therapies While Enrolled in North American Registry for Care and Research in Multiple Sclerosis

Abstract

We characterized patients with multiple sclerosis (MS) who were receiving oral disease-modifying therapies (DMTs) at enrollment compared with all MS patients in the North American Registry for Care and Research in Multiple Sclerosis (NARCRMS).